Publications by authors named "Paul Kelly Marcom"

Claim this Profile
T
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline Carriers With HER2-Negative Breast Cancer (the INFORM trial).
Nadine Tung, Banu Arun, Michele R Hacker, Erin Hofstatter, Deborah L Toppmeyer, Paul Kelly Marcom

J Clin Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
Caroline S Dorfman, Sarah S Arthur, Gretchen G Kimmick, Kelly W Westbrook, Paul Kelly Marcom

Menopause· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival.
Ashirbani Saha, Michael R Harowicz, Elizabeth Hope Cain, Allison H Hall, Eun-Sil Shelley Hwang, Paul Kelly Marcom

Breast Cancer Res Treat· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
Erik R Nelson, Shenduo Li, Margaret Kennedy, Sturgis Payne, Kelly Kilibarda, Paul Kelly Marcom

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.
Shenduo Li, Sturgis Payne, Fang Wang, Peter Claus, Zuowei Su, Paul Kelly Marcom

Breast Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic testing in the face of unclear clinical efficacy: lessons from cytochrome P450 2D6 for tamoxifen.
Jeffrey Peppercorn, Erika Hamilton, Paul Kelly Marcom, Laura Beskow, Gary H Lyman

Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.
Michael A Morse, Amy Hobeika, Takuya Osada, Donna Niedzwiecki, Paul Kelly Marcom

J Transl Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis